Connection
Catherine Lozupone to Double-Blind Method
This is a "connection" page, showing publications Catherine Lozupone has written about Double-Blind Method.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.033 |
|
|
|
-
Lomeli BK, Galbraith H, Schettler J, Saviolakis GA, El-Amin W, Osborn B, Ravel J, Hazleton K, Lozupone CA, Evans RJ, Bell SJ, Ochsner UA, Jarvis TC, Baqar S, Janjic N. Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota. Antimicrob Agents Chemother. 2019 12 20; 64(1).
Score: 0.033